Voyager Therapeutics operates as an independent, publicly traded corporate entity listed on the NASDAQ stock exchange under the ticker symbol VYGR. Because its shares are bought and sold publicly across open markets, it is collectively owned by a diverse base of institutional asset managers, mutual fund companies, venture capital firms, and individual retail investors. Executive management and the board of directors oversee day-to-day governance on behalf of the public shareholder community.